The table below shows the Pharma Stocks Below 1000 based on the Highest Market Capitalization.
| Name | Market Cap (Cr) | Close Price (₹) |
| Zydus Lifesciences Ltd | 98,027.32 | 982.45 |
| Piramal Pharma Ltd | 34,183.52 | 259 |
| Laurus Labs Ltd | 30,834.52 | 571.9 |
| Marksans Pharma Ltd | 14,523.90 | 320.5 |
| Granules India Ltd | 14,132.53 | 582.8 |
| Akums Drugs and Pharmaceuticals Ltd | 9,372.14 | 612.15 |
| Blue Jet Healthcare Ltd | 8,733.98 | 503.5 |
| Shilpa Medicare Ltd | 8,190.48 | 837.55 |
| F D C Ltd | 8,172.25 | 501.95 |
| Sun Pharma Advanced Research Co Ltd | 7,094.69 | 218.62 |
Content:
- What are Pharma Stocks?
- Best Pharma Stocks In India Below 1000
- Top Pharma Stocks Below 1000
- List Of best Pharma Stocks In India Below 1000
- Top 10 Pharma Stocks in India Below 1000
- Who Should Invest In Pharma Stocks Below 1000?
- How To Invest In The Pharma Stocks Below 1000?
- Performance Metrics Of Pharma Stocks Below 1000
- Benefits Of Investing In Pharma Stocks Below 1000
- Challenges Of Investing In Pharma Stocks Below 1000
- Introduction to Pharma Stocks Below 1000
- Top Pharma Stocks below 1000 – FAQs
What are Pharma Stocks?
Pharma stocks refer to shares of companies operating in the pharmaceutical industry. These companies research, develop, manufacture, and distribute pharmaceutical products, including prescription drugs, over-the-counter medications, and biotechnology products. Pharma stocks may also encompass companies involved in medical research, clinical trials, and healthcare services. Examples include pharmaceutical giants, biotech firms, and companies specializing in generic drugs or specialty pharmaceuticals.
Best Pharma Stocks In India Below 1000
The table below shows the Best Pharma Stocks In India Below 1000 based on 1 Year Return.
| Name | Close Price (₹) | 1Y Return (%) |
| Bacil Pharma Ltd | 60.53 | 1,073.06 |
| Strides Pharma Science Ltd | 748.25 | 217.93 |
| Nexus Surgical and Medicare Ltd | 25.69 | 202.24 |
| Supriya Lifescience Ltd | 770.6 | 185.2 |
| Gujarat Terce Laboratories Ltd | 85.25 | 185.12 |
| Chemo Pharma Laboratories Ltd | 128.54 | 184.44 |
| Shukra Pharmaceuticals Ltd | 72 | 169.69 |
| Fermenta Biotech Ltd | 414.95 | 169.45 |
| Source Natural Foods and Herbal Supplements Ltd | 225 | 159.22 |
| Gujarat Themis Biosyn Ltd | 326 | 156.49 |
Top Pharma Stocks Below 1000
The table below shows Top Pharma Stocks Below 1000 based on the highest day Volume.
| Name | Close Price (₹) | Daily Volume (Shares) |
| Nectar Lifesciences Ltd | 33.47 | 14,126,478 |
| Morepen Laboratories Ltd | 85.8 | 5,652,328 |
| Piramal Pharma Ltd | 259 | 5,064,831 |
| Syncom Formulations (India) Ltd | 22.78 | 3,848,223 |
| Johnson Pharmacare Ltd | 1.22 | 2,701,723 |
| Murae Organisor Ltd | 2.13 | 2,362,600 |
| Marksans Pharma Ltd | 320.5 | 1,729,916 |
| Vivanza Biosciences Ltd | 3.47 | 1,670,630 |
| Laurus Labs Ltd | 571.9 | 1,469,990 |
| Granules India Ltd | 582.8 | 1,220,753 |
List Of best Pharma Stocks In India Below 1000
The table below shows List Of best Pharma Stocks In India Below 1000 based on the PE Ratio.
| Name | Close Price (₹) | PE Ratio |
| IND Swift Laboratories Ltd | 120.48 | 1.69 |
| Ind Swift Ltd | 30.14 | 2.57 |
| Shelter Pharma Ltd | 54.4 | 10.14 |
| Transchem Ltd | 46.21 | 11.49 |
| Remedium Lifecare Ltd | 5.58 | 12.1 |
| Alpa Laboratories Ltd | 121.83 | 12.18 |
| Chemo Pharma Laboratories Ltd | 128.54 | 12.4 |
| Desh Rakshak Aushdhalaya Ltd | 15.04 | 12.48 |
| Zenith Drugs Ltd | 87.5 | 15.63 |
| Venus Remedies Ltd | 339.8 | 19.86 |
Top 10 Pharma Stocks in India Below 1000
The table below shows Top 10 Pharma Stocks in India Below 1000 based on the 6 month return.
| Name | Close Price (₹) | 6M Return (%) |
| Fermenta Biotech Ltd | 414.95 | 158.86 |
| Source Natural Foods and Herbal Supplements Ltd | 225 | 147.66 |
| Tiaan Consumer Ltd | 7.27 | 147.28 |
| JFL Life Sciences Ltd | 33 | 146.88 |
| Bacil Pharma Ltd | 60.53 | 135.71 |
| Supriya Lifescience Ltd | 770.6 | 109.97 |
| Desh Rakshak Aushdhalaya Ltd | 15.04 | 106.31 |
| Marksans Pharma Ltd | 320.5 | 103.38 |
| Astal Laboratories Ltd | 89.49 | 98.6 |
| Jagsonpal Pharmaceuticals Ltd | 663.15 | 96.37 |
Who Should Invest In Pharma Stocks Below 1000?
Investing in pharma stocks below 1000 can appeal to a wide range of investors. It may suit those seeking exposure to the healthcare sector with a moderate budget, including individuals interested in pharmaceutical innovations and medical advancements. Additionally, investors looking for defensive stocks with stable earnings and dividend yields, or those aiming to diversify their portfolios with healthcare investments may find pharma stocks below Rs.1000 attractive.
How To Invest In The Pharma Stocks Below 1000?
To invest in pharma stocks below Rs.1000, start by researching companies within the pharmaceutical sector. Identify leading pharmaceutical companies with stocks trading below Rs.1000 on the stock market. Open a brokerage account with a reputable platform, deposit funds, and place buy orders for the selected pharma stocks within your budget. Monitor your investments regularly and stay informed about industry developments and company performance.
Performance Metrics Of Pharma Stocks Below 1000
Performance metrics of Pharma Stocks Below 1000 Rs may include:
1. Revenue Growth: Reflects the rate at which the group’s companies increase their sales over time.
2. Earnings Per Share (EPS): Indicates the profitability of each share and the potential for dividend payouts.
3. Return on Equity (ROE): Measures how effectively the group’s companies are using shareholders’ equity to generate profits.
4. Price-to-Earnings (P/E) Ratio: Compares the current market price of the stock to its earnings per share, providing insight into its valuation.
5. Dividend Yield: Represents the percentage of dividends paid relative to the stock’s price, indicating the income generated for shareholders.
6. Debt-to-Equity Ratio: Measures the level of debt financing compared to equity financing, assessing the group’s financial leverage.
7. Total Shareholder Return (TSR): Reflects the total return generated for shareholders, including dividends and capital appreciation.
Benefits Of Investing In Pharma Stocks Below 1000
Advantages of investing in Pharma Stocks Below Rs.1000 :
- Growth Potential: Pharma stocks below Rs.1000 offer the potential for significant growth, especially if the companies have promising drug pipelines or are entering new markets.
- Defensive Nature: The healthcare sector, including pharmaceuticals, tends to be defensive, as demand for healthcare products remains relatively stable even during economic downturns.
- Dividend Income: Many pharmaceutical companies pay dividends, providing a source of income for investors.
- Innovation Opportunities: Investing in pharma stocks below Rs.1000 allows investors to participate in the innovative developments and breakthroughs in the pharmaceutical industry.
- Diversification: Adding pharma stocks to a portfolio below Rs.1000 can diversify risk and enhance overall portfolio performance, particularly if other sectors are underperforming.
Challenges Of Investing In Pharma Stocks Below 1000
Investing in Pharma Stocks Below 1000 Rs comes with certain challenges:
- Regulatory Risks: Pharma stocks face regulatory challenges, such as drug approvals, pricing regulations, and patent expirations, which can impact company earnings and stock performance.
- Clinical Trials: Investing in pharma stocks below Rs.1000 carries the risk of clinical trial failures, which can lead to setbacks in drug development and significant losses for investors.
- Competition: The pharmaceutical industry is highly competitive, with companies vying for market share and facing competition from generics, biosimilars, and other innovative therapies.
- Patent Expirations: Patent expirations on key drugs can result in revenue declines for pharmaceutical companies, leading to stock price volatility.
- Litigation Risks: Pharma companies may face legal challenges related to patent infringement, product liability, or regulatory violations, which can result in financial penalties and reputational damage.
Introduction to Pharma Stocks Below 1000
Pharma Stocks Below 1000 – Highest Market Capitalization
Zydus Lifesciences Ltd
The Market Cap of Zydus Lifesciences Ltd is ₹98,027.32 crore. The stock’s monthly return is 0.88%, and its one-year return is 55.06%. The stock is currently 55.45% away from its 52-week high.
Zydus Lifesciences Ltd is a leading Indian pharmaceutical company engaged in research, development, and manufacturing of a wide range of medical products. These include finished dosage formulations, biosimilars, vaccines, and active pharmaceutical ingredients (APIs). The company also has a strong portfolio in consumer wellness products and animal healthcare solutions. Notable products include Saroglitazar (Bilypsa) for NAFLD and NASH, and Desidustat (Oxemia) for anemia in chronic kidney disease patients.
In addition, Zydus has been at the forefront of innovation with products like ZyCoV-D, a DNA-based COVID-19 vaccine. The company is also advancing research in inflammation management with ZYIL1. Its strategic focus on generics and specialty formulations enables it to serve global markets effectively, contributing to its growing market presence and sustained financial performance.
Piramal Pharma Ltd
The Market Cap of Piramal Pharma Ltd is ₹34,183.52 crore. The stock’s monthly return is -8.49%, and its one-year return is 103.30%. The stock is currently 126.50% away from its 52-week high.
Piramal Pharma Ltd operates as a global leader in contract development and manufacturing organization (CDMO) services. It is involved in complex generics and consumer healthcare, offering solutions that include injectable products, APIs, and critical care formulations. The company has a strong presence in over 100 countries and serves the pharmaceutical, biotech, and generic sectors.
Piramal Pharma is known for its customer-centric approach, providing end-to-end solutions from development to delivery. It also maintains a robust pipeline in niche segments like oncology and anesthesia. This diversified portfolio and its commitment to innovation have helped the company achieve remarkable growth and cement its position as a trusted partner in global healthcare markets.
Laurus Labs Ltd
The Market Cap of Laurus Labs Ltd is ₹30,834.52 crore. The stock’s monthly return is 14.78%, and its one-year return is 46.36%. The stock is 58.49% away from its 52-week high.
Laurus Labs Ltd is a prominent pharmaceutical company specializing in APIs, generic finished dosage forms (FDFs), and synthesis services. With expertise in areas such as antiretrovirals, oncology, and cardiovascular drugs, the company serves leading global clients in over 50 countries. Its vertically integrated model ensures efficiency in operations and cost competitiveness.
The company’s commitment to research and development has enabled it to expand into biologics and other high-growth segments. Laurus Labs has also established a strong position in the green chemistry domain, focusing on sustainability and innovation. With a growing pipeline and capacity expansion, it is poised for long-term growth in both regulated and emerging markets.
Best Pharma Stocks In India Below 1000 – 1 Year Return
Bacil Pharma Ltd
The Market Cap of Bacil Pharma Ltd is ₹35.65 crore. The stock’s monthly return is 15.25%, and its one-year return is an astounding 1,073.06%. The stock is 1,193.38% away from its 52-week high.
Bacil Pharma Ltd is a niche player in the pharmaceutical sector, focused on manufacturing and supplying high-quality pharmaceutical products. The company’s product portfolio includes a range of formulations and APIs that cater to both domestic and international markets.
Despite its small market capitalization, Bacil Pharma has demonstrated extraordinary growth over the past year, highlighting its operational efficiency and market potential. Its focus on strategic partnerships and product innovation continues to drive its performance and visibility within the pharmaceutical industry.
Strides Pharma Science Ltd
The Market Cap of Strides Pharma Science Ltd is ₹6,896.08 crore. The stock’s monthly return is 6.46%, and its one-year return is 217.93%. The stock is currently 233.40% away from its 52-week high.
Strides Pharma Science Ltd is a global pharmaceutical company with a strong presence in regulated markets like the US, Europe, and Australia. It specializes in niche and complex generics, leveraging its state-of-the-art manufacturing facilities and robust R&D capabilities.
The company’s product portfolio spans key therapeutic areas such as oncology, HIV, and diabetes. Its focus on innovation and quality has enabled Strides to maintain a competitive edge in the global pharmaceutical landscape. With ongoing expansion plans, the company is well-positioned for sustained growth.
Nexus Surgical and Medicare Ltd
The Market Cap of Nexus Surgical and Medicare Ltd is ₹13.83 crore. The stock’s monthly return is 44.20%, and its one-year return is 202.24%. The stock is 202.24% away from its 52-week high.
Nexus Surgical and Medicare Ltd specializes in manufacturing surgical and medical equipment catering to hospitals and healthcare facilities. The company has gained attention for its high-quality products and commitment to healthcare innovation.
Despite its small scale, Nexus has shown exceptional growth in recent months, reflecting strong demand and operational resilience. Its focus on expanding product offerings and exploring new markets positions it well for future growth.
Top Pharma Stocks Below 1000 – Highest Day Volume
Nectar Lifesciences Ltd
The Market Cap of Nectar Lifesciences Ltd is ₹750.60 crore. The stock’s monthly return is -3.14%, and its one-year return is 15.81%. The stock is 27.99% away from its 52-week high.
Nectar Lifesciences Ltd is a vertically integrated pharmaceutical company engaged in manufacturing APIs, formulations, and biotech products. The company caters to both domestic and international markets, with a focus on regulated markets like the US and EU.
Its comprehensive product portfolio and cost-efficient operations make it a preferred partner for global clients. The company’s recent focus on R&D and capacity expansion highlights its commitment to innovation and sustainable growth.
Morepen Laboratories Ltd
The Market Cap of Morepen Laboratories Ltd is ₹4,701.44 crore. The stock’s monthly return is 4.09%, and its one-year return is 94.34%. The stock is 122.57% away from its 52-week high.
Morepen Laboratories Ltd is a leading pharmaceutical company in India, known for its APIs, finished formulations, and diagnostics products. The company has a strong presence in over 60 countries, offering key APIs like Montelukast and Atorvastatin. It is also a market leader in OTC products like Burnol and Lemolate.
Morepen’s robust diagnostic segment includes glucometers and testing kits, which have seen significant demand, particularly during the pandemic. The company’s consistent innovation and strategic partnerships underline its strong market position and potential for long-term growth.
Syncom Formulations (India) Ltd
The Market Cap of Syncom Formulations (India) Ltd is ₹2,070.82 crore. The stock’s monthly return is 15.50%, and its one-year return is 96.38%. The stock is 115.92% away from its 52-week high.
Syncom Formulations is engaged in manufacturing and exporting pharmaceutical formulations. The company offers a wide range of tablets, capsules, syrups, and ointments catering to both domestic and international markets. Its focus on quality and affordability has made it a trusted name in the industry.
The company has also ventured into herbal and ayurvedic formulations, expanding its portfolio. With increasing demand in global markets, Syncom continues to focus on operational efficiency and product innovation to sustain its growth momentum.
List Of best Pharma Stocks In India Below 1000 – PE Ratio
IND Swift Laboratories Ltd
The Market Cap of IND Swift Laboratories Ltd is ₹711.88 crore. The stock’s monthly return is 2.00%, and its one-year return is 29.27%. The stock is 39.77% away from its 52-week high.
IND Swift Laboratories is a leading player in the pharmaceutical sector, specializing in APIs and intermediates. The company serves regulated markets across the US, Europe, and Asia, with a focus on quality and compliance.
Its diversified product portfolio includes cardiovascular, anti-diabetic, and anti-allergic APIs. IND Swift’s strong manufacturing capabilities and strategic R&D investments position it as a competitive player in the pharmaceutical value chain.
Ind Swift Ltd
The Market Cap of Ind Swift Ltd is ₹163.25 crore. The stock’s monthly return is 36.27%, and its one-year return is 76.26%. The stock is 110.77% away from its 52-week high.
Ind Swift Ltd operates in the pharmaceutical formulations segment, offering a wide range of tablets, capsules, and syrups. The company is known for its quality and innovation in therapeutic areas like cardiovascular, anti-infective, and gastrointestinal drugs.
With a strong distribution network and focus on exports, Ind Swift has been able to achieve consistent growth. Its emphasis on operational efficiency and new product launches ensures sustained market competitiveness.
Shelter Pharma Ltd
The Market Cap of Shelter Pharma Ltd is ₹62.89 crore. The stock’s monthly return is 1.58%, and its one-year return is -12.23%. The stock is 32.36% away from its 52-week high.
Shelter Pharma Ltd is a niche pharmaceutical company specializing in herbal and ayurvedic formulations. The company’s product portfolio includes syrups, ointments, and tonics targeting various therapeutic areas.
Despite challenges in the past year, Shelter Pharma’s focus on traditional medicine and increasing global demand for herbal products position it for future growth. The company is leveraging R&D to innovate and expand its product offerings.
Fermenta Biotech Ltd
The Market Cap of Fermenta Biotech Ltd is ₹1,203.27 crore. The stock’s monthly return is 26.86%, and its one-year return is 169.45%. The stock is 186.17% away from its 52-week high.
Fermenta Biotech Ltd specializes in producing Vitamin D3 and other APIs. The company is a global leader in Vitamin D3 production, catering to dietary supplements, pharmaceuticals, and animal feed industries.
Fermenta’s focus on sustainability and innovation has helped it expand its portfolio and customer base. With a strong R&D setup and global partnerships, the company is poised for long-term growth in the health and wellness segment.
Source Natural Foods and Herbal Supplements Ltd
The Market Cap of Source Natural Foods and Herbal Supplements Ltd is ₹144.83 crore. The stock’s monthly return is -12.41%, and its one-year return is 159.22%. The stock is 188.46% away from its 52-week high.
Source Natural Foods specializes in herbal supplements and natural food products. The company offers a wide range of ayurvedic and plant-based products, catering to the growing demand for organic and natural healthcare solutions.
With increasing consumer awareness and global demand for natural products, Source Natural Foods is expanding its footprint in international markets. The company’s focus on quality and innovation ensures sustained growth opportunities.
Tiaan Consumer Ltd
The Market Cap of Tiaan Consumer Ltd is ₹7.49 crore. The stock’s monthly return is 9.82%, and its one-year return is 128.62%. The stock is 187.35% away from its 52-week high.
Tiaan Consumer Ltd operates in the fast-moving consumer goods (FMCG) sector, offering a range of health and wellness products. The company focuses on herbal and natural formulations to meet growing consumer preferences.
Despite its small size, Tiaan Consumer Ltd has shown remarkable growth, driven by its innovative product offerings and market expansion efforts. Its focus on customer-centric solutions positions it well for future growth in the FMCG space.
Top Pharma Stocks below 1000 – FAQs
Best Pharma Stocks Below 1000 Rs #1: Zydus Lifesciences Ltd
Best Pharma Stocks Below 1000 Rs #2: Piramal Pharma Ltd
Best Pharma Stocks Below 1000 Rs #3: Laurus Labs Ltd
Best Pharma Stocks Below 1000 Rs #4: Marksans Pharma Ltd
Best Pharma Stocks Below 1000 Rs #5: Granules India Ltd
Best Pharma Stocks Below 1000 Rs are based on market capitalization.
Based on one year’s return, the top 5 pharma stocks are Bacil Pharma Ltd, Strides Pharma Science Ltd, Nexus Surgical and Medicare Ltd, Supriya Lifescience Ltd, and Gujarat Terce Laboratories Ltd.
Yes, you can invest in pharma stocks below Rs.1000. Many pharmaceutical companies offer shares priced below Rs.1000, providing opportunities for investors to gain exposure to the sector at varying price points.
Investing in pharma stocks below Rs.1000 can be advantageous due to their growth potential, defensive nature, dividend income, innovation opportunities, and diversification benefits. However, it’s essential to consider regulatory risks, clinical trial outcomes, competition, patent expirations, and litigation risks.
To invest in pharma stocks below Rs.1000, research pharmaceutical companies trading at lower price points. Open a brokerage account, deposit funds, and purchase shares of selected pharma stocks through the stock market. Monitor industry developments, company performance, and regulatory changes to make informed investment decisions.
Here are some of the Best Stock Research Articles listed based on Top Sectors (Industries), Market Cap, and Fundamental Analysis Factors:
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
